Supplementary Table 1. Baseline characteristics and comparison between the analysis group and excluded group
Variables
Analysis group
N=416
Excluded group
N=271
p-value*
Age, mean (SD) 54.5 (9.0) 53.7 (9.6) 0.312
Gender, female, n (%) 131 (31.5) 89 (32.8) 0.711
Race, n (%) <0.001
Caucasian 308 (74.0) 185 (68.3)
African American 90 (21.6) 24 (8.9)
Hispanic 12 (2.9) 57 (21.0)
Other 6 (1.4) 5 (1.9)
BMI (kg/m2), mean (SD) 28.9 (5.8) 29.1 (5.6) 0.684
Cause of ESLD, n (%) 0.020
Alcoholic hepatitis 77 (18.5) 55 (20.3)
HCV 200 (48.1) 97 (35.8)
HCV/ Alcoholic hepatitis 15 (3.6) 14 (5.2)
NASH/Cryptogenic hepatitis 58 (13.9) 55 (20.3)
Other 66 (15.9) 50 (18.5)
Comorbidity: Diabetes, n (%) 112 (26.9) 62 (22.9) 0.233
Comorbidity: Hypertension, n (%) 163 (39.2) 84 (31.0) 0.029
MELD score, mean (SD) 18.2 (7.5) 19.0 (7.7) 0.171
Pre transplant ALT (IU/L), median (IQR) 39.0 (26.0, 60.5) 42.0 (29.0, 67.0) 0.222
Pre transplant AST (IU/L), median (IQR) 64.5 (44.0, 96.5) 67.0 (48.0, 101.0) 0.382
Pre transplant ALP (IU/L), median (IQR) 124.5 (95.0, 170.5) 134.0 (89.0, 182.0) 0.395

Pre transplant Bilirubin (mg/dL), median (IQR) 2.8 (1.7, 5.4) 3.2 (2.0, 6.3) 0.036
Pre transplant PT-INR, mean (SD) 1.7 (0.6) 1.8 (0.7) 0.135
Pre transplant WBC (103/μL), mean (SD) 5.6 (3.1) 5.4 (2.6) 0.368
Pre transplant Platelet (103/μL), median (IQR) 81.0 (58.0, 119.0) 77.0 (57.0, 103.0) 0.087
Pre transplant Creatinine (mg/dL), mean (SD) 1.2 (0.6) 1.2 (0.8) 0.908
Pre transplant eGFR (mL/min/1.73m2), mean (SD) 77.6 (33.1) 79.3 (34.6) 0.526
Pre transplant eGFR (mL/min/1.73m2), median (IQR) 75.7 (53.9, 100.4) 79.4 (50.8, 102.7) 0.495
Hemodialysis before LT within 2 weeks, n (%) 8 (1.9) 8 (3.0) 0.382
Hemodialysis before LT within 48 hours, n (%) 6 (1.4) 6 (2.2) 0.450
ACLF, n (%) 60 (14.4) 40 (14.8) 0.903
 ACLF with eGFR >30 mL/min/1.73m2 at LT, n (%) 32 (7.7) 24 (8.9)
0.799
 ACLF with eGFR <30 mL/min/1.73m2 at LT, n (%) 28 (6.7) 16 (5.9)
Donor information
Donor age, mean (SD) 41.4 (15.8) 41.1 (16.3) 0.781
Donor gender, female, n (%) 188 (45.2) 103 (38.0) 0.063
Donor race, n (%) 0.472
Caucasian 314 (75.5) 195 (72.0)
Hispanic 14 (3.4) 7 (2.6)
African American 82 (19.7) 62 (22.9)
Other 6 (1.4) 7 (2.6)
Abbreviations: ACLF: acute on chronic liver failure; BMI: body mass index; ESLD: end-stage liver disease; HCV: hepatitis C virus; 
NASH: non-alcoholic steatohepatitis; MELD: the model of end-stage liver disease; ALT: alanine aminotransferase; AST: aspartate 

aminotransferase; ALP: Alkaline Phosphatase; PT-INR: prothrombin time-international normalized ratio; WBC: white cell count; eGFR: 
estimated glomerular filtration rate; CLIF-SOFA: chronic liver failure - sequential organ failure- assessment; N/A: not available; N: 
numbers; SD: standard deviation; IQR: interquartile range
*P values for continuous variables with mean ± SD are results of t-test and with median (IQR) are results of Mann-Whitney test, and 
categorical variables are chi-square test

